Due to the high level of matrix complexity of cannabis products, mycotoxin testing in cannabis is very challenging. This study by Shimadzu focuses on developing a powerful detection method using an Integrated HPLC system that allows cannabis testing labs to confidently report concentrations below regulatory limits – Aflatoxins B1, B2, G1 and G2 combined to 20 ppb and 20 ppb for Ochratoxin A alone.
You can read the study here.
Shimadzu and select industry partners are planning a symposium for cannabis laboratory personnel at the end of March.
Experts from six organizations will be discussing topics such as medical cannabis, women in the cannabis industry, sample preparation, cannabis processing, quality data, investments and instruments for testing potency, terpenes, pesticides, residual solvents, heavy metals, moisture content, and mycotoxins.
The symposium will be held on March 30, 2017 in Columbia Maryland. There are no costs and lunch will be provided.
As medicinal and recreational cannabis markets continue to grow, analytical testing will ensure that consumers are receiving accurately labeled products that are free from contamination. With Shimadzu, Mandel is ready to help your laboratory adapt to the burgeoning field of medical cannabis.
Check out Shimadzu’s Cannabis Testing Laboratory Solutions brochure here.